The FDA plays a vital role in protecting the health of all U.S. citizens from the dangers posed by counterfeit Botox and other tainted medications.
Los Angeles, CA (PRWEB) January 09, 2013
The U.S. Food and Drug Administration (FDA) informed nearly 350 medical practices across the United States that they may have received counterfeit shipments of Botox products from a Canadian pharmaceutical provider. A copy of the letter sent by the FDA to these physicians’ can be found here (or go to: goo.gl/WC3fX).
According to the FDA's letter, the identified supplier, Canada Drugs, has been previously linked to the production and sale of counterfeit cancer medications in addition to the counterfeit Botox. These medications may also contain unknown ingredients or come from unknown sources. Such treatments are potentially unsafe and ineffective, and may put patients at risk of harm. These products often lack the proper medication guides and warnings that are required of non-FDA approved medications.
The FDA plays a vital role in protecting the health of all U.S. citizens from the dangers posed by counterfeit Botox and other tainted medications. The FDA has published a list of Doctors and practices that may have received counterfeit products. The list includes 48 firms in the state of California. Please ensure that your Doctor is not listed here.
For more information about fake Botox click here.
Epione Beverly Hills has been a pioneer in laser technology and non-invasive aesthetic procedures including Botox, Juvéderm, Radiesse, and Sculptra, as a means of treatment for conditions such as acne scarring, discoloration, wrinkles and stretch marks. For further information please contact (888) 951-3377 or visit http://www.epione.com/.